- April 22, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Synonyms :
Class :
may have a decreased diagnostic effect when combined with cosyntropin
may decrease the diagnostic effect when combined with metyrapone
cyproterone and ethinyl estradiol
may decrease the diagnostic effect of each other when combined
may increase the adverse effect
the therapeutic effect of anastrozole may be reduced by the use of estrogen derivatives
dehydroepiandrosterone may increase the adverse/toxic effects of estrogen derivatives
the therapeutic effect of exemestane may be reduced by the use of estrogen derivatives
the therapeutic effect of hemin may be reduced by the use of estrogen derivatives
may decrease the serum concentration of estrogen derivatives
may decrease the serum concentration of estrogen derivatives
may decrease the serum concentration of estrogen derivatives
may decrease the serum concentration of estrogen derivatives
may decrease the serum concentration of estrogen derivatives
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
they decrease the effect of thyroid products
they decrease the effect of thyroid products
they decrease the effect of thyroid products
they decrease the effect of thyroid products
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may enhance the concentration of serum when combined with corticosteroids
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may enhance the concentration of serum when combined with corticosteroids
May have an increased the thrombogenic effect when combined with anthrax immune globulin
May have an increased the thrombogenic effect when combined with anthrax immune globulin
May have an increased the thrombogenic effect when combined with anthrax immune globulin
May have an increased the thrombogenic effect when combined with anthrax immune globulin
May have an increased the thrombogenic effect when combined with anthrax immune globulin
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
It may diminish the metabolism when combined with Estrogens
human rabies immune globulin (HRIG)
may have an increased thrombogenic effect when combined with anthrax immune globulin
bazedoxifene/conjugated estrogens: nafcillin will decrease the effect of action of bazedoxifene/conjugated estrogens by affecting enzyme CYP3A4 metabolism or by altering intestinal flora.
when both drugs are combined, there may be a decreased effect of bazedoxifene/conjugated estrogens by altering intestinal flora
when both drugs are combined, there may be a decreased effect of bazedoxifene/conjugated estrogens by altering intestinal flora
cefprozil may reduce the therapeutic effects of oral forms of conjugated estrogen by altering gut microflora
cefaclor may reduce the therapeutic effects of oral forms of conjugated estrogen by altering gut microflora
when both drugs are combined, there may be an increased risk of adverse effects
cefepime may reduce the therapeutic effects of oral forms of conjugated estrogen by altering gut microflora
cefuroxime may reduce the therapeutic effects of oral forms of conjugated estrogen by altering gut microflora
it may decrease the serum concentration of Estrogen Derivatives
it may decrease the serum concentration of Estrogen Derivatives
it may decrease the serum concentration of Estrogen Derivatives
it may decrease the serum concentration of Estrogen Derivatives
it may decrease the serum concentration of Estrogen Derivatives
may diminish the therapeutic effect of ursodiol
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
CYP3A4 inhibitors (Strong) may increase the serum concentration of estrogen related drugs
may diminish the therapeutic effect of corticosteroids
may increase the serum concentration
may reduce the level of serum concentration of estrogen drugs
may reduce the level of serum concentration of estrogen drugs
may reduce the level of serum concentration of estrogen drugs
may reduce the level of serum concentration of estrogen drugs
may reduce the level of serum concentration of estrogen drugs
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the levels of serum concentration of estrogen derivatives
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
It may enhance the thrombogenic activities when combined with sotrovimab
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
estrogen Derivatives may lower the effectiveness of chenodiol
estrogen derivatives can enhance the hepatotoxic effect of dantrolene
It may increase the thrombogenic effect when combined with C1 inhibitors
The combination of estrogen derivatives with ajmaline could potentially amplify its harmful and toxic effects
The therapeutic efficacy of guanethidine may be reduced by estrogen derivative
The concentration serum of melatonin may be intensified by estrogen derivative
It may diminish the metabolism when combined with Ergot alkaloids
It may diminish the metabolism when combined with Ergot alkaloids
It may diminish the metabolism when combined with Ergot alkaloids
It may diminish the metabolism when combined with Ergot alkaloids
It may diminish the metabolism when combined with Ergot alkaloids
It may diminish the metabolism when combined with Endothelin receptor antagonists
It may diminish the metabolism when combined with Endothelin receptor antagonists
It may diminish the metabolism when combined with Endothelin receptor antagonists
could lead to a reduction in the concentration serum of Hormonal Contraceptives
